Jiutian Chemical Group Limited (SGX:C8R)

Intercept Pharmaceuticals Revenue

In the year 2024, Jiutian Chemical Group had annual revenue of 50.57M CNY, down -91.55%. Jiutian Chemical Group had revenue of -17.07M in the quarter ending December 31, 2024, a decrease of -113.63%.

• Revenue: 50.57M CNY
• Revenue Growth: -91.55%
• P/S Ratio: 5.47
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 51.70M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	50.57M	-548.00M	-91.55%
Dec 31, 2023	598.56M	-1.84B	-75.42%
Dec 31, 2022	2.43B	261.53M	12.03%
Dec 31, 2021	2.17B	1.03B	89.60%
Dec 31, 2020	1.15B	91.79M	8.71%